[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604014":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":45,"responsibleParty":63,"collaborators":26,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":26,"eligibilityCriteria":73,"healthyVolunteers":74,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":26,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":87,"overallStatus":48,"whyStopped":26,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Yuzuncu Yil University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Dexmedetomidine (Group-D)","ACTIVE_COMPARATOR","Group-D: Dexmedetomidine group (n:40). In rhinoplasty, 10 minute infusion of 0,5 mcg\u002Fkg dexmedetomidine will be administered after nasal packing.",[13],"Drug: Dexmedetomidine",{"label":15,"type":16,"description":17,"interventionNames":18},"Propofol (Group-P)","EXPERIMENTAL","Group-P: Propofol group (n:40). In rhinoplasty, 0,5 mg\u002Fkg propofol IV bolus will be administered after nasal packing.",[19],"Drug: Propofol",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Dexmedetomidine","In rhinoplasty, 10 minute infusion of 0,5 mcg\u002Fkg dexmedetomidine will be administered after nasal packing",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Propofol","In rhinoplasty, 0,5 mg\u002Fkg propofol IV bolus will be administered after nasal packing",[15],[32],{"name":33,"affiliation":5,"role":34},"Şükran Sevimli, Assoc. Prof.","STUDY_DIRECTOR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Mehmet Emin Keskin, assistant professor","CONTACT","+90 553 071 66 55","emin6559@hotmail.com",{"name":42,"role":38,"phone":43,"phoneExt":26,"email":44},"Bedrettin Bingöl, MD","+90 507 211 92 28","bedrettinbingolbb@gmail.com",[46],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":26,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"Van Yüzüncü Yıl University","RECRUITING","Van","Tuşba","65100","Turkey (Türkiye)",{"type":54,"coordinates":55},"Point",[56,57],43.38323,38.49457,{"lat":57,"lon":56},[60],{"name":33,"role":38,"phone":61,"phoneExt":26,"email":62},"+90 544 526 29 21","sevimli@hotmail.com",{"type":64,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Mehmet Emin Keskin","assistant professor","100604014","prevention-of-emergence-agitation-in-rhinoplasty-with-subanesthetic-propofol-and-single-dose-dexmedetomidine-a-prospective-double-blind-clinical-study-100604014",false,"NCT07144007","Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study","Van Yuzuncu Yil University Faculty of Medicine Ethics Committee","Inclusion Criteria:\n\n* Patients scheduled for rhinoplasty\n* Between 18-65 years\n* ASA I-II group\n\nExclusion Criteria:\n\n* Those who are outside the age range of 18-65\n* Those who are ASA III and above\n* Those with renal,hepatic, cardiac and respiratory diseases\n* Those with a known allergy to the medication to be used\n* Those who underwent urinary catheterization",true,"ALL","18 Years","65 Years",{"count":79,"type":80},80,"ESTIMATED","INTERVENTIONAL",[83],"NA","To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine",[86],"Emergence Agitation",[88,28,23,89],"emergence agitaion","Rhinoplasty","2025-08-26",{"date":92,"type":93},"2025-08-27","ACTUAL",{"date":95,"type":93},"2025-04-15",{"date":97,"type":80},"2026-02-01",{"name":5,"class":6},1]